Christine Haie-Meder

Author PubWeight™ 67.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006 6.44
2 Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol 2013 2.91
3 Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol 2008 2.23
4 Gynaecological cancers in pregnancy. Lancet 2012 2.11
5 Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes. Ann Surg Oncol 2004 1.75
6 Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). Int J Radiat Oncol Biol Phys 2005 1.75
7 Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012 1.54
8 Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol 2010 1.53
9 First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients. Gynecol Oncol 2004 1.37
10 Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol 2008 1.18
11 Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol 2012 1.17
12 Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 2008 1.17
13 Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 2007 1.16
14 Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results. Cancer 2008 1.10
15 Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol 2012 1.08
16 Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity. Ann Surg Oncol 2007 1.08
17 Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys 2009 1.07
18 Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist 2010 1.05
19 Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression. Int J Radiat Oncol Biol Phys 2003 1.04
20 [Role of radiotherapy in recurrent gliomas]. Bull Cancer 2004 1.00
21 Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique. Int J Gynecol Cancer 2011 1.00
22 New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET. Cancer Treat Rev 2008 0.99
23 Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer. Oncologist 2012 0.98
24 Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area. Oncologist 2011 0.96
25 Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol 2006 0.95
26 Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2010 0.94
27 Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies. J Am Coll Surg 2002 0.94
28 Overview of brachytherapy resources in Latin America: a patterns-of-care survey. Brachytherapy 2011 0.92
29 Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignancies. Brachytherapy 2010 0.91
30 Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases. Eur J Cancer 2010 0.90
31 Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary. Oncologist 2011 0.90
32 Adaptive 3D image-guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cancer. Oncologist 2013 0.89
33 Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol 2005 0.89
34 American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy. Brachytherapy 2013 0.89
35 Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. Int J Radiat Oncol Biol Phys 2007 0.89
36 Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy. Radiother Oncol 2008 0.88
37 Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression. Eur J Obstet Gynecol Reprod Biol 2006 0.87
38 Outcome after salvage radiotherapy (brachytherapy +/- external) in patients with a vaginal recurrence from endometrial carcinomas. Radiother Oncol 2002 0.86
39 Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys 2005 0.85
40 Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience. J Pediatr Surg 2009 0.84
41 [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma]. Bull Cancer 2005 0.82
42 [Effects of radiotherapy (external and/or internal) and chemotherapy on female fertility]. Bull Acad Natl Med 2010 0.82
43 Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging. Clin Imaging 2012 0.82
44 Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy. Radiother Oncol 2012 0.80
45 The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials. Eur J Cancer 2008 0.80
46 [Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)]. Bull Cancer 2003 0.80
47 Vulval and vaginal rhabdomyosarcoma in children: update and reappraisal of Institut Gustave Roussy brachytherapy experience. Int J Radiat Oncol Biol Phys 2008 0.80
48 Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma). Hum Reprod 2011 0.80
49 [Conservative management of malignant and borderline ovarian tumor]. Bull Cancer 2002 0.78
50 [Gynecological cancers and pregnancy: the point of view of the oncology gynecologist]. Bull Cancer 2002 0.78
51 Brachytherapy for T1-T2 floor-of-the-mouth cancers: the Gustave-Roussy Institute experience. Int J Radiat Oncol Biol Phys 2002 0.78
52 Brachytherapy for genital-tract rhabdomyosarcomas in girls: technical aspects, reports, and perspectives. Lancet Oncol 2007 0.78
53 Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience. Radiother Oncol 2004 0.77
54 Correlation between [18f]fluorodeoxyglucose positron-emission tomography scan and histology of pelvic nodes in early-stage cervical cancer. Anticancer Res 2010 0.77
55 [Medical treatment of metastatic or recurrent cancer of the cervix]. Bull Cancer 2006 0.77
56 Highly conformal therapy using proton component in the management of meningiomas. Preliminary experience of the Centre de Protonthérapie d'Orsay. Strahlenther Onkol 2002 0.77
57 Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience. Int J Gynecol Cancer 2015 0.76
58 Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy. Int J Gynaecol Obstet 2013 0.76
59 Cancer during pregnancy: the time has come for a prospective program. J Clin Oncol 2009 0.76
60 [Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment]. Bull Cancer 2013 0.76
61 Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy. Int J Gynecol Cancer 2010 0.76
62 Analysis of a continuous series of 34 young patients with early-stage cervical cancer selected for a vaginal radical trachelectomy: should "staging" conization be systematically performed before this procedure? Int J Gynecol Cancer 2013 0.76
63 Low-dose-rate definitive brachytherapy for high-grade vaginal intraepithelial neoplasia. Oncologist 2011 0.75
64 Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agents. Cancer Metastasis Rev 2008 0.75
65 Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer. J Am Coll Surg 2010 0.75
66 [Radiation therapy for chordomas and chondrosarcomas of the base of the skull and cervical spine]. Bull Cancer 2002 0.75
67 [PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]. Bull Cancer 2012 0.75
68 [What hysterectomy procedure should be carried out for cancer of the endometrium in stage I-II]. Bull Cancer 2002 0.75
69 Therapy Insight: fertility in women after cancer treatment. Nat Clin Pract Endocrinol Metab 2007 0.75
70 Laparoscopic radical hysterectomy after preoperative brachytherapy for stage IB1 cervical cancer: feasibility, results, and surgical implications in a large bicentric study of 162 consecutive cases. Ann Surg Oncol 2012 0.75
71 [French recommendations for endometrial cancer 2010: clinical use and questions still debated]. Bull Cancer 2012 0.75
72 Clear cell adenocarcinoma of the female genital tract: long-term outcome and fertility aspects after brachytherapy aimed at a conservative treatment. Int J Gynecol Cancer 2012 0.75
73 Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: a report of the REACT working group of ESTRO. Radiother Oncol 2004 0.75
74 Sentinel lymph node in endometrial cancer: a review. Curr Oncol Rep 2013 0.75
75 Image-guided adaptive brachytherapy in locally advanced cervical cancer: recent advances and perspectives. Curr Opin Oncol 2016 0.75
76 Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95. Pediatr Blood Cancer 2013 0.75
77 [Sentinel lymph nodes in gynecologic cancers]. Bull Cancer 2002 0.75